GuanWJNiZYHuY, et al.Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med2020; 382: 1708–1720. doi:10.1056/NEJMoa2002032.
2.
OxleyTJMoccoJMajidiS, et al.Large-vessel Stroke as a presenting feature of Covid-19 in the young. N Engl J Med2020; 382(20): e60doi:10.1056/NEJMc2009787.
3.
MaoLJinHWangM, et al.Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol2020; 77(6): 683–690.
4.
HelmsJKremerSMerdjiH, et al.Neurologic features in severe SARS-CoV-2 infection. N Engl J Med2020; 382(23): 2268–2270. doi:10.1056/NEJMc2008597.
5.
LodigianiCIapichinoGCarenzoL, et al.Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res2020; 191: 9–14. doi:10.1016/j.thromres.2020.04.024.
6.
ColombiDBodiniFCPetriniM, et al.Well-aerated lung on admitting chest CT to predict adverse outcome in COVID-19 pneumonia. Radiology2020, pp. 201433doi:10.1148/radiol.2020201433.
7.
KishoreAKVailAChamorroA, et al.How is pneumonia diagnosed in clinical stroke research? A systematic review and meta-analysis. Stroke2015; 46(5): 1202–1209. doi:10.1161/STROKEAHA.114.007843.
8.
GiannisDZiogasIAGianniP. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol2020; 127: 104362doi:10.1016/j.jcv.2020.104362.
9.
HenryBMVikseJBenoitSFavaloroEJLippiG. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta2020; 507: 167–173. doi:10.1016/j.cca.2020.04.027.
